table of content
1 Introduction to Research & Analysis Reports
1.1 Adoptive Cell Transfer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adoptive Cell Transfer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adoptive Cell Transfer Therapy Overall Market Size
2.1 Global Adoptive Cell Transfer Therapy Market Size: 2022 VS 2032
2.2 Global Adoptive Cell Transfer Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adoptive Cell Transfer Therapy Players in Global Market
3.2 Top Global Adoptive Cell Transfer Therapy Companies Ranked by Revenue
3.3 Global Adoptive Cell Transfer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adoptive Cell Transfer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adoptive Cell Transfer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Adoptive Cell Transfer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Adoptive Cell Transfer Therapy Market Size Markets, 2022 & 2032
4.1.2 NK
4.1.3 LAK
4.1.4 DC
4.1.5 CIK
4.1.6 CTL
4.1.7 TIL
4.1.8 TCR-T
4.1.9 CAR-T
4.2 By Type - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
4.2.1 By Type - Global Adoptive Cell Transfer Therapy Revenue, 2018-2023
4.2.2 By Type - Global Adoptive Cell Transfer Therapy Revenue, 2024-2032
4.2.3 By Type - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adoptive Cell Transfer Therapy Market Size, 2022 & 2032
5.1.2 Acute Lymphocytic Leukemia
5.1.3 NHL
5.1.4 Melanoma
5.1.5 Bladder Cancer
5.1.6 Lung Cancer
5.1.7 Head and Neck Cancer
5.1.8 Multiple Myeloma
5.1.9 Other
5.2 By Application - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
5.2.1 By Application - Global Adoptive Cell Transfer Therapy Revenue, 2018-2023
5.2.2 By Application - Global Adoptive Cell Transfer Therapy Revenue, 2024-2032
5.2.3 By Application - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Adoptive Cell Transfer Therapy Market Size, 2022 & 2032
6.2 By Region - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
6.2.1 By Region - Global Adoptive Cell Transfer Therapy Revenue, 2018-2023
6.2.2 By Region - Global Adoptive Cell Transfer Therapy Revenue, 2024-2032
6.2.3 By Region - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.3.2 US Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.3.3 Canada Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.3.4 Mexico Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.4.2 Germany Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.3 France Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.4 U.K. Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.5 Italy Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.6 Russia Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.8 Benelux Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.5.2 China Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.3 Japan Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.4 South Korea Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.6 India Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.6.2 Brazil Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.6.3 Argentina Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.7.2 Turkey Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7.3 Israel Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7.5 UAE Adoptive Cell Transfer Therapy Market Size, 2018-2032
7 Adoptive Cell Transfer Therapy Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Adoptive Cell Transfer Therapy Major Product Offerings
7.1.4 Novartis AG Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Company Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma Adoptive Cell Transfer Therapy Major Product Offerings
7.2.4 Kite Pharma Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.2.5 Kite Pharma Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Adoptive Cell Transfer Therapy Major Product Offerings
7.3.4 Pfizer Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Company Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.4.4 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.4.5 Juno Therapeutics Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Major Product Offerings
7.5.4 Celgene Corporation Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 CARsgen Therapeutics
7.6.1 CARsgen Therapeutics Company Summary
7.6.2 CARsgen Therapeutics Business Overview
7.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.6.4 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.6.5 CARsgen Therapeutics Key News & Latest Developments
7.7 Sorrento Therapeutics
7.7.1 Sorrento Therapeutics Company Summary
7.7.2 Sorrento Therapeutics Business Overview
7.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.7.4 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.7.5 Sorrento Therapeutics Key News & Latest Developments
7.8 Legend Biotech
7.8.1 Legend Biotech Company Summary
7.8.2 Legend Biotech Business Overview
7.8.3 Legend Biotech Adoptive Cell Transfer Therapy Major Product Offerings
7.8.4 Legend Biotech Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.8.5 Legend Biotech Key News & Latest Developments
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Company Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.9.4 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.9.5 Atara Biotherapeutics Key News & Latest Developments
7.10 Aurora Biopharma
7.10.1 Aurora Biopharma Company Summary
7.10.2 Aurora Biopharma Business Overview
7.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Major Product Offerings
7.10.4 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.10.5 Aurora Biopharma Key News & Latest Developments
7.11 Autolus Therapeutics PLC
7.11.1 Autolus Therapeutics PLC Company Summary
7.11.2 Autolus Therapeutics PLC Business Overview
7.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Major Product Offerings
7.11.4 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.11.5 Autolus Therapeutics PLC Key News & Latest Developments
7.12 Bluebird
7.12.1 Bluebird Company Summary
7.12.2 Bluebird Business Overview
7.12.3 Bluebird Adoptive Cell Transfer Therapy Major Product Offerings
7.12.4 Bluebird Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.12.5 Bluebird Key News & Latest Developments
7.13 Carina Biotech
7.13.1 Carina Biotech Company Summary
7.13.2 Carina Biotech Business Overview
7.13.3 Carina Biotech Adoptive Cell Transfer Therapy Major Product Offerings
7.13.4 Carina Biotech Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.13.5 Carina Biotech Key News & Latest Developments
7.14 Athenex
7.14.1 Athenex Company Summary
7.14.2 Athenex Business Overview
7.14.3 Athenex Adoptive Cell Transfer Therapy Major Product Offerings
7.14.4 Athenex Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.14.5 Athenex Key News & Latest Developments
7.15 Xiangxue Pharmaceutical (Xiangxue Precision)
7.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Summary
7.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
7.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Major Product Offerings
7.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Key News & Latest Developments
7.16 Hengrui Yuanzheng
7.16.1 Hengrui Yuanzheng Company Summary
7.16.2 Hengrui Yuanzheng Business Overview
7.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Major Product Offerings
7.16.4 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.16.5 Hengrui Yuanzheng Key News & Latest Developments
7.17 Eureka Therapeutics
7.17.1 Eureka Therapeutics Company Summary
7.17.2 Eureka Therapeutics Business Overview
7.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.17.4 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.17.5 Eureka Therapeutics Key News & Latest Developments
7.18 WuXi Juno
7.18.1 WuXi Juno Company Summary
7.18.2 WuXi Juno Business Overview
7.18.3 WuXi Juno Adoptive Cell Transfer Therapy Major Product Offerings
7.18.4 WuXi Juno Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.18.5 WuXi Juno Key News & Latest Developments
7.19 Shenzhen Inno Immunity
7.19.1 Shenzhen Inno Immunity Company Summary
7.19.2 Shenzhen Inno Immunity Business Overview
7.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Major Product Offerings
7.19.4 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.19.5 Shenzhen Inno Immunity Key News & Latest Developments
7.20 Shenzhen Binde Bio
7.20.1 Shenzhen Binde Bio Company Summary
7.20.2 Shenzhen Binde Bio Business Overview
7.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Major Product Offerings
7.20.4 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.20.5 Shenzhen Binde Bio Key News & Latest Developments
7.21 Kerui Bio
7.21.1 Kerui Bio Company Summary
7.21.2 Kerui Bio Business Overview
7.21.3 Kerui Bio Adoptive Cell Transfer Therapy Major Product Offerings
7.21.4 Kerui Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.21.5 Kerui Bio Key News & Latest Developments
7.22 Adaptimmune
7.22.1 Adaptimmune Company Summary
7.22.2 Adaptimmune Business Overview
7.22.3 Adaptimmune Adoptive Cell Transfer Therapy Major Product Offerings
7.22.4 Adaptimmune Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.22.5 Adaptimmune Key News & Latest Developments
7.23 Altor Bioscience Corporation
7.23.1 Altor Bioscience Corporation Company Summary
7.23.2 Altor Bioscience Corporation Business Overview
7.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Major Product Offerings
7.23.4 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.23.5 Altor Bioscience Corporation Key News & Latest Developments
7.24 Cellectis
7.24.1 Cellectis Company Summary
7.24.2 Cellectis Business Overview
7.24.3 Cellectis Adoptive Cell Transfer Therapy Major Product Offerings
7.24.4 Cellectis Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.24.5 Cellectis Key News & Latest Developments
7.25 Takara Bio
7.25.1 Takara Bio Company Summary
7.25.2 Takara Bio Business Overview
7.25.3 Takara Bio Adoptive Cell Transfer Therapy Major Product Offerings
7.25.4 Takara Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.25.5 Takara Bio Key News & Latest Developments
7.26 Unum Therapeutics
7.26.1 Unum Therapeutics Company Summary
7.26.2 Unum Therapeutics Business Overview
7.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.26.4 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.26.5 Unum Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
